BlackRock Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$130K	Buy	41,078 +2,427	+6%	+$7.45K	﹤0.01%	2911
2016 Q3	$132K	Buy	38,651 +4,148	+12%	+$11.5K	﹤0.01%	2898
2016 Q2	$79K	Buy	34,503 +5,033	+17%	+$12.3K	﹤0.01%	3072
2016 Q1	$74K	Sell	29,470 -2,475	-8%	-$5.52K	﹤0.01%	3052
2015 Q4	$106K	Sell	31,945 -10,631	-25%	-$31.8K	﹤0.01%	2895
2015 Q3	$103K	Sell	42,576 -5,765	-12%	-$14.9K	﹤0.01%	3088
2015 Q2	$142K	Buy	48,341 +4,910	+11%	+$19K	﹤0.01%	3009
2015 Q1	$174K	Buy	43,431 +4,644	+12%	+$16.1K	﹤0.01%	2757
2014 Q4	$117K	Sell	38,787 -1,667	-4%	-$4.51K	﹤0.01%	2952
2014 Q3	$103K	Sell	40,454 -148,749	-79%	-$358K	﹤0.01%	2983
2014 Q2	$466K	Buy	189,203 +1,701	+0.9%	+$3.84K	﹤0.01%	2062
2014 Q1	$498K	Buy	187,502 +151,405	+419%	+$446K	﹤0.01%	2049
2013 Q4	$105K	Buy	36,097 +4,868	+16%	+$14.7K	﹤0.01%	3017
2013 Q3	$96K	Buy	31,229 +2,516	+9%	+$7.96K	﹤0.01%	2983
2013 Q2	$92K	Buy	+28,713	New	+$92K	﹤0.01%	2944